| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47967e03e28cc94c34fad66dae2a5721
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebf9c85ffc15093825d7a1506af88b7d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
| filingDate |
2009-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7920bd944305ebb9b54163602e6e084 |
| publicationDate |
2010-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010003232-A1 |
| titleOfInvention |
Treating cancer using atractyloside |
| abstract |
The present invention provides a composition of atractyloside (ATR) or carboxyatractyloside (CATR) for treating cancer. Treatment of tumours with ATR is shown to suppress tumour growth and to enhance median survival times in a breast cancer model. ATR compositions are also shown to be useful in treating tumours refractory to other chemotherapeutic regimens. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115607676-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112022864-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113274420-A |
| priorityDate |
2008-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |